Literature DB >> 6994785

Experiences with guanfacine in a two-year follow-up study.

G Titscher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6994785      PMCID： PMC1430133          DOI： 10.1111/j.1365-2125.1980.tb04911.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Pharmacology of BS 100-141, a centrally acting antihypertensive drug.

Authors:  K Saameli; G Scholtysik; R Waite
Journal:  Clin Exp Pharmacol Physiol       Date:  1975       Impact factor: 2.557

2.  Clinical dose-response studies with guanfacine (BS 100-141), a new antihypertensive agent.

Authors:  P MacCarthy; P Isaac; G Frost; A Freeman; G Stokes
Journal:  Clin Exp Pharmacol Physiol       Date:  1978 Mar-Apr       Impact factor: 2.557

3.  [First experiences with BS 100-141, a new antihypertensive substance].

Authors:  I Esch
Journal:  Int J Clin Pharmacol Biopharm       Date:  1976-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.